A double-blind, placebo-controlled trial of adding erythropoietin to intravenous methylprednisolone for the treatment of unilateral acute optic neuritis of unknown or demyelinative origin
Crossref DOI link: https://doi.org/10.1007/s00417-014-2925-7
Published Online: 2015-01-22
Published Print: 2015-05
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Shayegannejad, Vahid
Shahzamani, Shima
Dehghani, Alireza
Dast Borhan, Zahra
Rahimi, Marzie
Mirmohammadsadeghi, Arash
Text and Data Mining valid from 2015-01-22